Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT05027256 Completed - Cancer Clinical Trials

Entia Liberty: Usability Validation

Start date: September 12, 2022
Phase:
Study type: Observational

This study forms part of Entia's clinical evidence for regulatory submission. This study evaluates Entia Liberty's validation of the device. Participants will be trained to take an Entia Liberty test in a simulated home environment and a trained healthcare professional will perform another test from the same participant (different finger) on a separate device. The results will be compared. Usability data will be observed and the participants will complete a questionnaire after the tests have been performed.

NCT ID: NCT05025124 Completed - Cancer Clinical Trials

Entia Liberty: Accuracy and Precision

Start date: October 3, 2022
Phase:
Study type: Observational

This study forms part of Entia's clinical evidence for regulatory submission. This study evaluates Entia Liberty's performance claims with venous blood compared to the gold standard clinical laboratory haematology analysers. Excess blood flagged by the laboratory meeting our requirements will be tested on the Entia Liberty device and have its results compared against the laboratory results. Samples will also be flagged for precision testing (same blood sample, split into 10 Entia Liberty samples).

NCT ID: NCT05025111 Completed - Cancer Clinical Trials

Entia Liberty: Capillary Validation

Start date: September 12, 2022
Phase:
Study type: Observational

This study is a clinical performance validation study to evaluate the performance of the Entia Liberty device. Patients undergoing routine venepuncture blood tests will be recruited to have an Entia Liberty test (by finger-prick) done on them by a trained healthcare professional. The results from that finger-prick test will be compared against the results from the routine venepuncture blood test (reference method) and subsequently, excess blood from the routine venepuncture test will be run on another Entia Liberty device in the laboratory. All three results (Entia Liberty capillary, Entia Liberty venous and gold standard venous) will be compared against each other to prove Entia Liberty's performance claims.

NCT ID: NCT05021393 Completed - Cancer Clinical Trials

Clinical Pharmacists' Intervention on Pain Management in Cancer Patients

PharmCaP
Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The study aims to evaluate the impact of clinical pharmacist intervention as a part of a multidisciplinary team to improve clinical outcomes of cancer patients with pain in comparison to standard care.

NCT ID: NCT05012904 Completed - Pain Clinical Trials

Using Parental Involvement During Venipuncture to Reduce Venipuncture Pain and Anxiety in Children With Cancer

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study aims to determine whether parental involvement during venipuncture reduces venipuncture pain and anxiety in children with cancer.

NCT ID: NCT05010239 Completed - Cancer Clinical Trials

The Immediate Effect of Mindfulness-Based Supportive Therapy on Palliating Suffering in Palliative Care Cancer Patients

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The was a parallel group, single-blinded, randomized controlled trial comparing the effectiveness of 30-minute mindfulness-based supportive therapy versus supportive listening in reducing suffering among patients with cancer. This study was conducted in the University Malaya Medical Centre, from 1st august 2020 to 31 December 2020.

NCT ID: NCT05002842 Completed - Cancer Clinical Trials

Implementation of Mind-Body Practices in an Online Community of Caring (CaringBridge)

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

CaringBridge (CB) is an online health community for people undergoing challenging health journeys. This platform provides an opportunity for individuals and their caregivers to rally support for a loved-one during a health journey. CaringBridge offers the opportunity for expressive writing through journal entries, wellbeing resources, participant health journey stories, and practical scheduling and communication tools to support community, healing, and wellbeing. Loving Kindness Meditation (LKM) is a systemized mind-body approach developed to increase loving acceptance and has been shown to increase resilience in the face of adversity. The aim of this study is to better understand how mind-body practices, like LKM, impact adult CB users

NCT ID: NCT04978805 Completed - Cancer Clinical Trials

Progressive Relaxation Exercise on Dyspnea, Pain and Sleep Quality

Progressive
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

This study was planned to examine the effect of progressive relaxation exercises applied to lung cancer patients receiving chemotherapy on dyspnea, pain and sleep quality.

NCT ID: NCT04967209 Completed - Breast Cancer Clinical Trials

Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer

Start date: July 5, 2021
Phase:
Study type: Observational

This mixed methods study will involve obtaining user feedback on the first 4 weeks of the Healthy Habits for Cancer (HCC) Program. Short pre and post surveys and in-depth qualitative interviews will be conducted exploring their views on the app (features they liked and didn't like), the extent to which they believe the app would have to be further adapted, how they would feel about such an app being embedded in their cancer care and when in their care pathway they would like to be offered it.

NCT ID: NCT04956783 Completed - Cancer Clinical Trials

Occurrence of Adverse Effects With Immune Checkpoint Inhibitors Between a Single and Double Dose Regimen

ICI DODO
Start date: June 1, 2021
Phase:
Study type: Observational

This is a retrospective evaluation of the impact of a double dose regimen of immunotherapy use in cancer treatment compared to the single-dose regimen on the occurrence of clinically significant adverse events. The aim of this study is to provide evidence-based arguments to help clinicians to propose the best treatment regimen for each patient.